Annual Total Liabilities
$26.51 M
+$1.12 M+4.42%
31 December 2023
Summary:
ChromaDex annual total liabilities is currently $26.51 million, with the most recent change of +$1.12 million (+4.42%) on 31 December 2023. During the last 3 years, it has risen by +$4.57 million (+20.85%). CDXC annual total liabilities is now at all-time high.CDXC Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$22.15 M
-$1.16 M-4.99%
30 September 2024
Summary:
ChromaDex quarterly total liabilities is currently $22.15 million, with the most recent change of -$1.16 million (-4.99%) on 30 September 2024. Over the past year, it has dropped by -$4.02 million (-15.37%). CDXC quarterly total liabilities is now -24.64% below its all-time high of $29.40 million, reached on 30 June 2019.CDXC Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CDXC Total Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +4.4% | -15.4% |
3 y3 years | +20.9% | -11.4% |
5 y5 years | +76.1% | +38.5% |
CDXC Total Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +20.9% | -18.1% | at low |
5 y | 5 years | at high | +76.1% | -18.1% | +38.5% |
alltime | all time | at high | >+9999.0% | -24.6% | >+9999.0% |
ChromaDex Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $22.15 M(-5.0%) |
June 2024 | - | $23.32 M(-7.2%) |
Mar 2024 | - | $25.13 M(-5.2%) |
Dec 2023 | $26.51 M(+4.4%) | $26.51 M(+1.3%) |
Sept 2023 | - | $26.18 M(+0.6%) |
June 2023 | - | $26.02 M(+1.0%) |
Mar 2023 | - | $25.75 M(+1.4%) |
Dec 2022 | $25.39 M(-2.8%) | $25.39 M(+3.0%) |
Sept 2022 | - | $24.64 M(-4.6%) |
June 2022 | - | $25.84 M(-4.5%) |
Mar 2022 | - | $27.05 M(+3.6%) |
Dec 2021 | $26.11 M(+19.1%) | $26.11 M(+4.4%) |
Sept 2021 | - | $25.00 M(+5.5%) |
June 2021 | - | $23.70 M(-5.8%) |
Mar 2021 | - | $25.16 M(+14.7%) |
Dec 2020 | $21.93 M(+10.8%) | $21.93 M(+22.3%) |
Sept 2020 | - | $17.93 M(-12.2%) |
June 2020 | - | $20.41 M(+7.1%) |
Mar 2020 | - | $19.06 M(-3.7%) |
Dec 2019 | $19.80 M(+31.5%) | $19.80 M(+23.8%) |
Sept 2019 | - | $16.00 M(-45.6%) |
June 2019 | - | $29.40 M(+40.3%) |
Mar 2019 | - | $20.95 M(+39.2%) |
Dec 2018 | $15.05 M(+69.3%) | $15.05 M(+10.5%) |
Sept 2018 | - | $13.62 M(+16.7%) |
June 2018 | - | $11.67 M(+8.2%) |
Mar 2018 | - | $10.78 M(+21.3%) |
Dec 2017 | $8.89 M(-9.1%) | $8.89 M(+10.2%) |
Sept 2017 | - | $8.06 M(+12.0%) |
June 2017 | - | $7.20 M(-38.3%) |
Mar 2017 | - | $11.68 M(+19.4%) |
Dec 2016 | $9.78 M(-27.4%) | $9.78 M(+41.6%) |
Sept 2016 | - | $6.91 M(+29.5%) |
June 2016 | - | $5.33 M(-47.2%) |
Mar 2016 | - | $10.11 M(-25.0%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2015 | $13.47 M(+79.2%) | $13.47 M(+25.8%) |
Sept 2015 | - | $10.71 M(+3.7%) |
June 2015 | - | $10.33 M(+41.5%) |
Mar 2015 | - | $7.30 M(-3.0%) |
Dec 2014 | $7.52 M(+126.4%) | $7.52 M(+79.2%) |
Sept 2014 | - | $4.20 M(-8.0%) |
June 2014 | - | $4.56 M(+24.0%) |
Mar 2014 | - | $3.68 M(+10.7%) |
Dec 2013 | $3.32 M(-34.1%) | $3.32 M(-26.4%) |
Sept 2013 | - | $4.51 M(+20.2%) |
June 2013 | - | $3.75 M(-5.8%) |
Mar 2013 | - | $3.98 M(-21.0%) |
Dec 2012 | $5.04 M(+35.9%) | $5.04 M(+20.0%) |
Sept 2012 | - | $4.20 M(-8.5%) |
June 2012 | - | $4.59 M(-1.4%) |
Mar 2012 | - | $4.66 M(+25.6%) |
Dec 2011 | $3.71 M(+136.0%) | $3.71 M(+34.7%) |
Sept 2011 | - | $2.75 M(+6.5%) |
June 2011 | - | $2.58 M(+17.7%) |
Mar 2011 | - | $2.20 M(+39.8%) |
Dec 2010 | $1.57 M(-37.6%) | $1.57 M(-16.7%) |
Sept 2010 | - | $1.89 M(+4.3%) |
June 2010 | - | $1.81 M(-42.7%) |
Mar 2010 | - | $3.15 M(+25.3%) |
Dec 2009 | $2.52 M(+7.9%) | $2.52 M(+5.0%) |
Sept 2009 | - | $2.40 M(+3.9%) |
June 2009 | - | $2.31 M(-4.2%) |
Mar 2009 | - | $2.41 M(+3.2%) |
Dec 2008 | $2.33 M(>+9900.0%) | $2.33 M(-27.1%) |
Sept 2008 | - | $3.20 M(-5.5%) |
June 2008 | - | $3.39 M(>+9900.0%) |
Feb 2008 | - | $3300.00(+725.0%) |
Nov 2007 | $400.00 | $400.00(-20.0%) |
Aug 2007 | - | $500.00(0.0%) |
May 2007 | - | $500.00(0.0%) |
Feb 2007 | - | $500.00 |
FAQ
- What is ChromaDex annual total liabilities?
- What is the all time high annual total liabilities for ChromaDex?
- What is ChromaDex annual total liabilities year-on-year change?
- What is ChromaDex quarterly total liabilities?
- What is the all time high quarterly total liabilities for ChromaDex?
- What is ChromaDex quarterly total liabilities year-on-year change?
What is ChromaDex annual total liabilities?
The current annual total liabilities of CDXC is $26.51 M
What is the all time high annual total liabilities for ChromaDex?
ChromaDex all-time high annual total liabilities is $26.51 M
What is ChromaDex annual total liabilities year-on-year change?
Over the past year, CDXC annual total liabilities has changed by +$1.12 M (+4.42%)
What is ChromaDex quarterly total liabilities?
The current quarterly total liabilities of CDXC is $22.15 M
What is the all time high quarterly total liabilities for ChromaDex?
ChromaDex all-time high quarterly total liabilities is $29.40 M
What is ChromaDex quarterly total liabilities year-on-year change?
Over the past year, CDXC quarterly total liabilities has changed by -$4.02 M (-15.37%)